Pain Disengagement Training (Open Pilot)
RecruitingNot applicableNCT06870162
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators aim to conduct an open pilot trial to determine the initial feasibility of a self-directed writing-based intervention in individuals with chronic musculoskeletal pain and elevated pain catastrophizing. The investigators will assess the feasibility of recruitment, acceptability of the treatment, credibility and participant satisfaction, treatment adherence, and feasibility of assessments following pre-specified benchmarks.
Study details
- Official title
- Pain Disengagement Training: A Self-directed Intervention for Pain Catastrophizing (Open Pilot)
- Conditions
- Interventions
- Behavioral: Pain Disengagement Training
- Sponsor
- Massachusetts General Hospital
- Collaborators
- National Center for Complementary and Integrative Health (NCCIH)
- Start date
- 2025-10-14
- Primary completion
- 2026-12-10
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Outpatient adults (i.e., greater than or equal to 18) 2. Has self reported chronic musculoskeletal pain (i.e., pain persisting for at least 3 months) 3. Pain score greater than or equal to 4 (moderate) on the Numerical Rating Scale 4. Pain catastrophizing score greater than or equal to 20 on Pain Catastrophizing Scale 5. Willingness to engage in a writing-based intervention and self-reported ability to write or type for at least 30 minutes in a sitting 6. Received care at Massachusetts General Hospital 7. English verbal and writing fluency Exclusion Criteria: 1. Clinically significant change in therapy or medication in the past 3 months 2. Severe untreated mental health condition (e.g., psychosis) 3. Active suicidality with history of plan or current intent 4. Serious illness expected to worsen in the next 6 months (e.g., cancer) 5. Untreated substance use problem that, per patient's self-report, would interfere with the ability to complete the intervention.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06870162